Skip to content

Seminar Title

 

Synergy Satellite: Evidence and pharmacovigilance of monoclonal antibody reference and biosimilar products (sponsored by an educational grant from Roche)

Affiliation

Karolinska Institute, Stockholm

Country

Sweden

1. Current Status, Position

Mr Mellstedt is Professor of Oncologic Biotherapy at the Karolinska Institute, CancerCentre Karolinska at the Karolinska University Hospital Solna, Stockholm.

2. Education

  • 1996-1999: MD, PhD at the Karolinska Institute, Professor of Experimental Oncology at Uppsala University and Academic Hospital.
  • Since 1999: Professor of Oncologic Biotherapy at Karolinska Insitute.
  • Board certified in Internal Medicine, Hematology and Oncology.
  • 2004-2009: ESMO President.

3. Research Area

  • Immune biology of B-lymphoproliferative diseases and gastrointestinal cancer. 
  • Development of monoclonal antibody therapy and cancer vaccine in malignant B-cell disorders, colorectal and pancreatic carcinoma. 
  • Development of therapeutic monoclonal antibodies and thyrosine kinase receptors against the RTK ROR. 
  • He has published more than 500 scientific articles within these areas and written numerous chapters in text books.
 
Conflict of interest: Håkan Mellstedt has received honoraria from Abbvie, Amgen, Bio-Sweden, Boeringer-Ingelheim, Hospira, Roche and research grants from Merck GmBH.
Håkan Mellstedt has served on ad hoc SAB for Abbvie, Amgen, Boeringer-Ingelheim, Hospira.


×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.